Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AI-Empowered Expert Prescription Intervention for Improving Cardiovascular Prognosis Among Primary-Care Hypertensive Populations: A Cluster-Randomized Controlled Trial

NCT07845448 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Nanchang University as lead sponsor.

NCT NCT07845448
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07845448 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AI-Empowered Expert Prescription Intervention for Improving Cardiovascular Prognosis Among Primary-Care Hypertensive Populations: A Cluster-Randomized Controlled Trial
Lead sponsor
Second Affiliated Hospital of Nanchang University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 10, 2026
Completion date
September 9, 2031
Enrollment
14,400 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

all cause mortality, cardiovascular, cardiovascular mortality, coronary heart disease, diabete mellitus, dyslipidaemia, heart failure, hypertension, ischemic heart disease, major adverse cardiac event (mace), stroke